Global Cushing’s Disease Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1015

Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.
Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
In 2018, the global Cushing’s Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cushing’s Disease Treatment development in United States, Europe and China.

The key players covered in this study
CORCEPT THERAPEUTICS
HRA Pharma
Strongbridge Biopharma
Novartis
...

Market segment by Type, the product can be split into
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies 

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cushing’s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Cushing’s Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cushing’s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cushing’s Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Ketoconazole
1.4.3 Mitotane
1.4.4 Aminoglutethimide
1.4.5 Metyrapone
1.4.6 Mifepristone
1.4.7 Etomidate
1.4.8 Pasireotide
1.5 Market by Application
1.5.1 Global Cushing’s Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Clinics
1.5.6 E-Commerce/Online Pharmacies 
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cushing’s Disease Treatment Market Size
2.2 Cushing’s Disease Treatment Growth Trends by Regions
2.2.1 Cushing’s Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Cushing’s Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cushing’s Disease Treatment Market Size by Manufacturers
3.1.1 Global Cushing’s Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Cushing’s Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cushing’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Cushing’s Disease Treatment Key Players Head office and Area Served
3.3 Key Players Cushing’s Disease Treatment Product/Solution/Service
3.4 Date of Enter into Cushing’s Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cushing’s Disease Treatment Market Size by Type (2014-2019)
4.2 Global Cushing’s Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Cushing’s Disease Treatment Market Size (2014-2019)
5.2 Cushing’s Disease Treatment Key Players in United States
5.3 United States Cushing’s Disease Treatment Market Size by Type
5.4 United States Cushing’s Disease Treatment Market Size by Application

6 Europe
6.1 Europe Cushing’s Disease Treatment Market Size (2014-2019)
6.2 Cushing’s Disease Treatment Key Players in Europe
6.3 Europe Cushing’s Disease Treatment Market Size by Type
6.4 Europe Cushing’s Disease Treatment Market Size by Application

7 China
7.1 China Cushing’s Disease Treatment Market Size (2014-2019)
7.2 Cushing’s Disease Treatment Key Players in China
7.3 China Cushing’s Disease Treatment Market Size by Type
7.4 China Cushing’s Disease Treatment Market Size by Application

8 Japan
8.1 Japan Cushing’s Disease Treatment Market Size (2014-2019)
8.2 Cushing’s Disease Treatment Key Players in Japan
8.3 Japan Cushing’s Disease Treatment Market Size by Type
8.4 Japan Cushing’s Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cushing’s Disease Treatment Market Size (2014-2019)
9.2 Cushing’s Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Cushing’s Disease Treatment Market Size by Type
9.4 Southeast Asia Cushing’s Disease Treatment Market Size by Application

10 India
10.1 India Cushing’s Disease Treatment Market Size (2014-2019)
10.2 Cushing’s Disease Treatment Key Players in India
10.3 India Cushing’s Disease Treatment Market Size by Type
10.4 India Cushing’s Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Cushing’s Disease Treatment Market Size (2014-2019)
11.2 Cushing’s Disease Treatment Key Players in Central & South America
11.3 Central & South America Cushing’s Disease Treatment Market Size by Type
11.4 Central & South America Cushing’s Disease Treatment Market Size by Application

12 International Players Profiles
12.1 CORCEPT THERAPEUTICS
12.1.1 CORCEPT THERAPEUTICS Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cushing’s Disease Treatment Introduction
12.1.4 CORCEPT THERAPEUTICS Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.1.5 CORCEPT THERAPEUTICS Recent Development
12.2 HRA Pharma
12.2.1 HRA Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cushing’s Disease Treatment Introduction
12.2.4 HRA Pharma Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.2.5 HRA Pharma Recent Development
12.3 Strongbridge Biopharma
12.3.1 Strongbridge Biopharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cushing’s Disease Treatment Introduction
12.3.4 Strongbridge Biopharma Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.3.5 Strongbridge Biopharma Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cushing’s Disease Treatment Introduction
12.4.4 Novartis Revenue in Cushing’s Disease Treatment Business (2014-2019)
12.4.5 Novartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details